0 items USD 0.00Search
- Did you mean
- crohn diseases
Your search for "Crohn’s disease" gave back 77813 results.
The wireless motility/pH capsule (WMC) is an orally ingested, nondigestible, data recording device that enables the simultaneous assessment of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2023
Price: USD 2,900.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
March 2014
Price: USD 551.00
Integrin Beta 7 - Pipeline Review, H2 2019 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Integrin beta-7 is an integrin...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
August 2019
Price: USD 3,500.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
The global In-vitro Inflammatory Bowel Disease Diagnostic market size was valued at USD million in 2023 and is forecast to a readjusted size of USD...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
November 2024
Price: USD 3,480.00
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
February 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2023
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
March 2022
Price: USD 3,500.00
Ìý
Filter By Report Date
Filter By Industry
Filter By Country
- Global (77435) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Â鶹Դ´s (1) Apply Emerging Â鶹Դ´s filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
